# Gabapentin in the Post-cesarean Pain Management of Buprenorphine Patient

> **NCT03335436** · PHASE4 · WITHDRAWN · sponsor: **Vanderbilt University Medical Center**

## Conditions studied

- Cesarean Delivery
- Pain Management

## Interventions

- **DRUG:** Gabapentin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03335436
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-04-01
- **Primary completion:** 2020-11
- **Final completion:** 2020-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2019-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03335436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03335436, "Gabapentin in the Post-cesarean Pain Management of Buprenorphine Patient". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03335436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*